tiprankstipranks
Trending News
More News >
Ci Medical Co., Ltd. (JP:3540)
:3540
Japanese Market

Ci Medical Co., Ltd. (3540) Ratios

Compare
0 Followers

Ci Medical Co., Ltd. Ratios

JP:3540's free cash flow for Q4 2024 was ¥0.35. For the 2024 fiscal year, JP:3540's free cash flow was decreased by ¥ and operating cash flow was ¥0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.23 0.86 1.23 4.11 3.35
Quick Ratio
0.60 0.44 0.60 2.35 2.18
Cash Ratio
0.15 0.08 0.15 1.04 1.20
Solvency Ratio
0.25 0.15 0.25 0.80 0.62
Operating Cash Flow Ratio
0.12 >-0.01 0.12 0.45 0.88
Short-Term Operating Cash Flow Coverage
0.20 >-0.01 0.20 0.00 0.00
Net Current Asset Value
¥ 2.17B¥ -3.52B¥ 2.17B¥ 10.51B¥ 10.72B
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.41 0.23 0.00 0.00
Debt-to-Equity Ratio
0.39 0.86 0.39 0.00 0.00
Debt-to-Capital Ratio
0.28 0.46 0.28 0.00 0.00
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.00 0.00
Financial Leverage Ratio
1.66 2.07 1.66 1.25 1.37
Debt Service Coverage Ratio
0.44 0.17 0.44 0.00 0.00
Interest Coverage Ratio
665.00 175.82 665.00 0.00 0.00
Debt to Market Cap
0.14 0.41 0.14 0.00 0.00
Interest Debt Per Share
141.96 344.23 141.96 0.00 0.00
Net Debt to EBITDA
1.22 3.86 1.22 -0.75 -1.14
Profitability Margins
Gross Profit Margin
27.22%26.29%27.22%28.16%30.20%
EBIT Margin
8.99%6.56%8.99%10.98%12.58%
EBITDA Margin
10.23%8.80%10.23%11.82%13.30%
Operating Profit Margin
9.30%6.55%9.30%10.98%12.57%
Pretax Profit Margin
8.98%6.98%8.98%10.40%11.90%
Net Profit Margin
5.88%4.56%5.88%6.84%7.81%
Continuous Operations Profit Margin
5.89%4.60%5.89%6.85%7.81%
Net Income Per EBT
65.46%65.39%65.46%65.81%65.62%
EBT Per EBIT
96.52%106.52%96.52%94.74%94.64%
Return on Assets (ROA)
8.35%5.02%8.35%14.16%15.45%
Return on Equity (ROE)
13.84%10.38%13.84%17.65%21.23%
Return on Capital Employed (ROCE)
21.26%14.48%21.26%27.59%33.20%
Return on Invested Capital (ROIC)
11.38%5.22%11.38%18.16%21.79%
Return on Tangible Assets
8.85%5.24%8.85%14.71%16.03%
Earnings Yield
4.98%4.96%4.98%6.08%4.63%
Efficiency Ratios
Receivables Turnover
14.09 13.98 14.09 16.13 10.06
Payables Turnover
18.05 19.49 18.05 19.99 16.29
Inventory Turnover
4.32 3.92 4.32 4.80 4.71
Fixed Asset Turnover
3.10 2.23 3.10 9.92 24.19
Asset Turnover
1.42 1.10 1.42 2.07 1.98
Working Capital Turnover Ratio
6.31 -251.39 6.31 3.74 3.78
Cash Conversion Cycle
90.17 100.56 90.17 80.44 91.29
Days of Sales Outstanding
25.91 26.10 25.91 22.63 36.28
Days of Inventory Outstanding
84.49 93.19 84.49 76.07 77.42
Days of Payables Outstanding
20.23 18.73 20.23 18.26 22.40
Operating Cycle
110.40 119.29 110.40 98.70 113.70
Cash Flow Ratios
Operating Cash Flow Per Share
28.18 -3.12 28.18 31.56 83.18
Free Cash Flow Per Share
-158.78 -181.74 -158.78 -25.06 74.02
CapEx Per Share
186.96 178.62 186.96 56.62 9.16
Free Cash Flow to Operating Cash Flow
-5.63 58.24 -5.63 -0.79 0.89
Dividend Paid and CapEx Coverage Ratio
0.15 -0.02 0.15 0.46 6.83
Capital Expenditure Coverage Ratio
0.15 -0.02 0.15 0.56 9.08
Operating Cash Flow Coverage Ratio
0.20 >-0.01 0.20 0.00 0.00
Operating Cash Flow to Sales Ratio
0.03 >-0.01 0.03 0.04 0.11
Free Cash Flow Yield
-15.69%-21.64%-15.69%-2.70%5.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.07 20.17 20.07 16.44 21.61
Price-to-Sales (P/S) Ratio
1.18 0.92 1.18 1.12 1.69
Price-to-Book (P/B) Ratio
2.78 2.09 2.78 2.90 4.59
Price-to-Free Cash Flow (P/FCF) Ratio
-6.37 -4.62 -6.37 -36.99 17.05
Price-to-Operating Cash Flow Ratio
35.91 -269.20 35.91 29.37 15.17
Price-to-Earnings Growth (PEG) Ratio
-1.90 -1.16 -1.90 -4.80 0.23
Price-to-Fair Value
2.78 2.09 2.78 2.90 4.59
Enterprise Value Multiple
12.75 14.33 12.75 8.77 11.54
Enterprise Value
55.96B 57.49B 55.96B 42.70B 57.42B
EV to EBITDA
12.75 14.33 12.75 8.77 11.54
EV to Sales
1.30 1.26 1.30 1.04 1.54
EV to Free Cash Flow
-7.05 -6.33 -7.05 -34.08 15.51
EV to Operating Cash Flow
39.72 -368.53 39.72 27.06 13.81
Tangible Book Value Per Share
331.46 366.90 331.46 304.70 261.40
Shareholders’ Equity Per Share
364.34 401.22 364.34 319.56 275.12
Tax and Other Ratios
Effective Tax Rate
0.34 0.34 0.34 0.34 0.34
Revenue Per Share
857.83 912.65 857.83 824.11 747.86
Net Income Per Share
50.42 41.64 50.42 56.40 58.40
Tax Burden
0.65 0.65 0.65 0.66 0.66
Interest Burden
1.00 1.06 1.00 0.95 0.95
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.11 0.13 0.11 0.10 0.10
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.37 -0.07 0.37 0.37 0.93
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis